A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag
Clinical trial NCT04567602 · COMPLETED
Trial details
- NCT number
- NCT04567602
- Sponsor
- Janssen-Cilag S.p.A.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-06
- Primary completion
- 2024-01-25
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.